Search for: "Ely Lilly"
Results 1141 - 1160
of 2,157
Sorted by Relevance
|
Sort by Date
18 Jun 2009, 8:17 am
Long Island Railroad, finding that because there was no direct connection between Eli Lily's warnings and the victim, finding a duty from Lilly to decedent would be tantamount to Lily owing a duty to everyone. [read post]
17 Sep 2010, 7:33 am
Eli Lilly and Company, __ F.3d __, 2010 WL 3516183 (2d Cir. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v… [read post]
3 Mar 2008, 9:27 pm
" Eli Lilly, 119 F.3d at 1568, 43 USPQ2d at 1406. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
17 Feb 2018, 7:30 am
”Henry loved when he was in "shear mode"Claim "Interpretation" - it is all about what you say and disclaimWith the old "Construction" heading now replaced with "Interpretation", Mr Justice Carr stated he would be applying"principles concerning normal interpretation and equivalents set out by the Supreme Court in Actavis v Eli Lilly [2017] UKSC 48, [2018] and by the Patents Court in Mylan v Yeda [2017] EWHC 2629 (Pat) at [134]… [read post]
29 Jun 2015, 9:36 am
In the brand-new Court of Appeal decision just out - Actavis UK Ltd & Others v Eli Lilly & Company [2015] EWCA Civ 555 (25 June 2015), Lord Justice Floyd (Lords Justices Kitchin and Longmore concurring) disagreed with Arnold J on two main issues. [read post]
23 Feb 2016, 1:53 am
Mrs Justice Rose is go go go in Lilly v Janssen stay applicationStays of proceedings are not easy in UK courts, as Janssen found out last week in Eli Lilly v Janssen Sciences [2016] EWHC 313, where Mrs Justice Rose refused to stay Lilly's revocation and declaration of non-infringement (DNI) action brought against Janssen's divisional patent - EP (UK) 2 305 282. [read post]
8 Aug 2017, 12:10 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
18 Aug 2017, 5:56 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
15 Feb 2010, 8:49 am
Eli Lilly: This en banc case is fully briefed and pending decision on the question of whether the written description requirement of Section 112 should be considered separate and distinct from the enablement requirement. [read post]
4 Mar 2010, 5:22 am
Eli Lilly: Written Description Requirement The North Face versus The South Butt Patent Examiner Experience Levels Inequitable Conduct Based on Contradictory Statements to the EPO (in a non-family member application) False Marking False Marking False Marking False Marking all at up to $500 per offense Viagra, Cialis, & Levitra: Board of Patent Appeals Affirms Rejection of Pfizer’s Broad Patent over ED Treatment [read post]
1 Nov 2006, 1:58 am
Robert Armitage, in-house counsel at Eli Lilly ranked 51st and earned $1.17 million. [read post]
29 Dec 2010, 6:25 am
Some attorneys plan to also sue drug company Eli Lilly, which pioneered the drugs prior to selling them in 2002 to AAI Pharmaceuticals, which has since gone bankrupt. [read post]
22 May 2008, 4:34 am
In a post Maybe It Isn't Going to Get Much Better, Patent Docs discusses Bessen/Meurer.Patent Docs refers to Professor Wegner who questions some of the implausible numbers found in the Bessen/Meurer book:Further, Professor Wegner notes that when Eli Lilly and Company lost its patent on Prozac ® in 2001, "its market cap dropped $36 billion in one day, roughly triple what the authors say is the annual profit for the entire pharmaceutical and chemistry industries… [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
27 Jul 2020, 2:04 am
The department said in a business review letter that it would allow Eli Lilly and Co., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
28 Aug 2012, 2:19 pm
September 13-14:The America Invents Act: One Year Later Keynote Speakers: David Kappos, Director, USPTO Robert Armitage, General Counsel, Eli Lilly and Company September 24: The State of Patent Litigation: A Conversation with the Federal Circuit Keynote Speakers: Hon. [read post]
3 Nov 2011, 6:51 am
Other pharma companies have cracked the billion-dollar threshold, including Eli Lilly & Co., which agreed to pay $1.4 billion over sales of its Zyprexa anti-psychotic medicine. [read post]
